Trial intelligence / Profile preview

Hesperetin and Sucrose on Glucose Regulation Part 2

NCT06340087Phase 1Completed

Sponsor
University of Vienna
Start
Mar 2024
Primary completion
Sep 2024
Countries
1
01

Overview

Phase 1, randomised, single-blind trial (3 arms), sponsored by University of Vienna. Primary endpoints: Change in blood glucose concentration, Change in appetite score and 1 more. Started Mar 2024; status: completed.

Beyond the preview

Go deeper on NCT06340087.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06340087.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call